Fasiclo-SP Tablet is a potent combination medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (15mg), designed to provide effective relief from pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), works by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol acts as an analgesic and antipyretic, helping to alleviate mild to moderate pain and reduce fever. Serratiopeptidase, a proteolytic enzyme, aids in reducing inflammation and swelling by breaking down protein-based exudates and promoting faster healing. This combination is commonly prescribed for conditions such as osteoarthritis, rheumatoid arthritis, musculoskeletal injuries, postoperative pain, and dental pain. Fasiclo-SP Tablet offers a synergistic effect, targeting pain, inflammation, and associated swelling simultaneously, thus enhancing patient comfort and mobility. It is generally well-tolerated but should be used under medical supervision, especially in individuals with a history of gastrointestinal issues, liver or kidney impairment, or allergies to NSAIDs. Patients are advised to follow the prescribed dosage and consult their healthcare provider if symptoms persist or adverse effects occur.